Candriam SCA’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-70,000
Closed -$176K 808
2020
Q3
$176K Sell
70,000
-1,159,346
-94% -$2.91M ﹤0.01% 759
2020
Q2
$16.7M Buy
+1,229,346
New +$16.7M 0.18% 144
2019
Q4
Sell
-300,000
Closed -$1.18M 788
2019
Q3
$1.18M Hold
300,000
0.02% 581
2019
Q2
$1.45M Hold
300,000
0.02% 581
2019
Q1
$2.46M Hold
300,000
0.03% 453
2018
Q4
$1.66M Buy
300,000
+230,000
+329% +$1.27M 0.03% 496
2018
Q3
$618K Buy
+70,000
New +$618K 0.01% 687
2015
Q1
Sell
-76,485
Closed -$890K 636
2014
Q4
$890K Buy
+76,485
New +$890K 0.02% 453